Skip to content

Roche has completed the acquisition of Good Therapeutics for $250M, plus milestones.
The Good team is excited to continue its groundbreaking work at Bonum Therapeutics. Stay tuned for more.

Systemic Delivery,
Local Activity

Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.